Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

ASCO Guideline Update: Use of Endocrine Therapy for Breast Cancer Risk Reduction

Oncology Practice Insider

On September 3, 2019, ASCO posted the "Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline Update". The decision regarding choice of endocrine therapy should take into consideration age, baseline comorbidities, and adverse effect profiles. Slides, a recommendations table, decision aid, patient information, pocketcard, and visual abstract are available. There is also a podcast interview with panel members.